CannabisNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) Files Patents Related to Method-of-Use and Composition-of-Matter Claims for Non-Selective Bio-Herbicide

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based biological crop protection products, today announced the filing of patents related to method-of-use and composition-of-matter claims for a biological non-selective bio-herbicide, based on its signature mustard-derived approach to controlling unwanted pests and diseases. According to the update, MustGrow has completed a series of application rate tests with Canada’s National Research Council to determine the applicability of its natural mustard-derived technology as a bio-pesticide. Herbicidal control of trial plants from the root up was achieved after only 72 hours, with the strong data validating MustGrow’s natural science-based approach, utilizing the mustard seed’s natural defense mechanism, not only as a bio-pesticide, but also as a bio-herbicide. “The efficacious properties of our active ingredient as a bio-pesticide, bio-nematicide and bio-herbicide represent a key milestone for MustGrow,” Colin Bletsky, COO of MustGrow, said in the news release.  “MustGrow has plans to further expand our data set and focus testing on hard to kill and herbicide-resistant weeds as well as to expand applications of our remarkable natural mustard-based technology.”

To view the full press release, visit http://cnw.fm/nXgH7

About MustGrow

MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) agricultural biotech company focused on providing natural science-based biological solutions for high value crops, including fruit & vegetable and cannabis cultivation. MustGrow has designed and owns a United States EPA-approved organic solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. This product, in granule format, is EPA-approved across all key U.S. states as a bio-fertilizer and bio-pesticide (currently limited to a bio-fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit & vegetable bio-pesticide and bio-fertilizer. MustGrow has now concentrated a liquid format to be applied through standard drip or spray equipment, improving functionality and performance features.

In cannabis, MustGrow is currently developing effective, safe and biological solutions that adhere to Health Canada’s strict regulations, including (1) its mustard-derived bio-pesticide to treat soil-borne pests and diseases; and (2) an in-licensed bio-fungicide for powdery mildew.

The Company has approximately 36.2 million basic common shares issued and outstanding and approximately 54.9 million on a fully diluted basis. For further details please visit www.MustGrow.ca.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Canadian Study Finds That Marijuana Could Treat PTSD-Induced Depression

People with PTSD (post-traumatic stress disorder) often suffer from depression and bouts of suicidal ideations. Research shows these people can treat this depression with marijuana.

The University of British Columbia and the B.C Centre of Substance use (BCCSU) conducted a study that shows that pot could be used to treat PTSD-induced depression.

The study researchers analyzed data of 24,000 Canadians from Statistics Canada. Their findings were published in the Journal of Psychopharmacology.

The researchers found that people who used marijuana did not suffer from PTSD-induced depression, but those who did not consume marijuana were found to have significant episodes of depression and suicidal tendencies. The BCCSU researchers suggest that people with PTSD should use cannabis for its therapeutic effects.

A PhD candidate at the University of British Columbia and research associate at the BCCSU, Stephanie Lake, said that due to the limited options for treating PTSD effectively, patients are self-medicating with marijuana to manage their symptoms.

Before this study, there was no evidence to show that the therapeutic effects of marijuana could be used for patients with PTSD. The study finding gives PTSD patients new hope when seeking alternative treatment options.

The researchers say that the data from Statistics Canada shows that there is a correlation between trauma from injury, violence, and disaster, and depression and suicide. The researchers further noted that Canada has one of the highest rates of PTSD, with 9.2 percent of the population suffering from the condition.

From 24,000 eligible participants, the researchers found that 420 (1.7%) had a current diagnosis of PTSD. Of the 420, twenty percent reported having used marijuana within the past year. 11 percent of the 420 did not use marijuana in the past year.

Compared to non-marijuana users without PTSD, chances of experiencing depression or suicidal thoughts were seven times more in people who did not use marijuana and were suffering from PTSD.

According to the study, PTSD sufferers who used marijuana were not associated with recent episodes of depression or thoughts of suicide.

The researchers also found that people using marijuana and have post-traumatic stress disorder comprised of more than a quarter of all Canadian citizens. The percentage of people with PTSD and using marijuana is estimated at 11.4 percent.

The study provides evidence of the effective use of cannabis in reducing the possibility of depression and suicidal tendencies among patients with post-traumatic stress disorder. These findings must be good news to marijuana industry players like Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Mustgrow Biologics Corp. (CSE: MGRO) who have always known that the therapeutic uses of marijuana are yet to be fully documented.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – University of Maryland Mulls Offering a Master’s in Marijuana

Summer Kriegshauser is a Washington DC denizen studying for her second master’s degree online. Each day before she goes to work, she logs in to a website and goes through her lectures and classwork. She is hopeful that she will be able to change careers with additional qualifications. She is studying for a Masters of Science in Medical Cannabis Science and Therapeutics.

Kriegshauser is one of the 150 students who are the pioneers of the marijuana masters graduate program at the University of Maryland, Baltimore, in the U.S.

This is a standalone program. However, some universities are providing students with one-off classes on marijuana, and two others have created an undergraduate degree in medicinal plant chemistry, but none has gone as far as Maryland by offering a master’s degree in cannabis.

The program is carried out over a period of two years, and the highest percentage of the courses are online-based. The program comes at a time when the number of states legalizing marijuana for both medical and recreational use is on the rise.  This is creating ever-expanding opportunities for people looking to grow in the cannabis industry, and given the dynamism of the marijuana industry and laws related to weed, the possibilities are bound to keep expanding.

Expertise in marijuana is gained through experience as the industry continues to grow. Those looking to make a career in the marijuana industry are taking a risky gamble because the likelihood of finding a job can be tasking in such fluid circumstances.

Kriegshauser says that she loves everything marijuana, but quitting her job to work at a marijuana dispensary to learn about marijuana was out of the question. She wanted to learn the properties of cannabis, all the compounds such as CBD, and how they interact with the body. She also wanted to learn about dosing and medical marijuana qualifying ailments.

According to the program director Dr. Leah Sera, the university officials at the school of pharmacy noticed that most of their graduates were entering a professional world where marijuana was viewed as an alternative medicine used for treating several illnesses.

Studies show that there is an educational gap when it comes to medical marijuana. Health professionals are requesting that more education on marijuana be availed since patients turn to them when they have a question related to cannabis and therapeutic uses, said Dr. Sera.

Several cannabis programs are being launched in different states across the U.S, and it would be irresponsible if the pharmacy professionals do not act on it.

The idea for the program was first conceived by the school’s dean, Natalie D. Eddington. She received the go-ahead from the Board of Regents and the state’s higher education authorities in May and June, respectively. The Attorney-General gave his go-ahead after he was assured that the students would not be handling marijuana in the school compound.

The university intended for the inaugural class to consist of 50 students, but they were forced to increase the number to 150 after an overwhelming number of 506 individuals applied. The class has students from different states and countries such as Hong Kong and Australia. The required number of courses is four and some electives.

Kriegshauser said that although there is much uncertainty when it comes to getting a job, she is confident that her master’s degree will enhance her professional career.

Industry watchers and the entire cannabis industry, including players like MustGrow Biologics Corp. (CSE: MGRO) and Marijuana Company of America Inc. (OTCQB: MCOA) are glad that higher education institutions are taking the initiative to bridge the knowledge and skills gap existing in the marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Colorado Supreme Court to Decide on Medical Marijuana Rights of People on Probation

Is it fair for people on probation to present additional proof of their need for medical marijuana to judges? The Colorado Supreme Court is set to make a decision on this matter. This comes after Alysha Walton agreed to probation after she was arrested for speeding and driving under the influence and pleaded guilty in El Paso County in 2017. Her lawyer requested a hearing where he argued that she be allowed to continue receiving medical marijuana while serving her sentence, but the judge said that her doctor would have to testify.

Data from the Department of Public Health and Environment in Colorado shows that there are at least 80,000 people who have valid medical marijuana cards, and a quarter of these are patients from El Paso County. Therefore, it is hard to predict how many people have issues with these kinds of stipulations as conditions for those on probation.

No doctor was willing to testify on her behalf; therefore, Walton appeared at her hearing with only her medical card and a letter from a doctor despite being advised otherwise by the court. Eventually, the court ruled against her, and she was required to stop using medical marijuana during her probation. The Colorado Public Defenders office argued that the restriction was an abuse of the court’s power by the judge since she presented the documentation needed to support her need for medical marijuana.

According to Jay Tiftickjian, a law allowing people on probation to use medical marijuana was passed in 2015, although it is still not clear to what extent this law is being implemented because he still gets countless emails from people on probation requiring to use medical marijuana but are not allowed. Due to the colossal amount of inquiries, his firm added a page to their website for answering some of the common questions.

According to Tiftickjian, a judge’s view on weed can affect his decision where one judge may permit the use of medical cannabis while another may issue a strict sentence when asked for permission to seek medical marijuana treatment.

Tiftickjian had a client, John West, who was arrested for driving under the influence of alcohol in Jefferson County. The Judge gave West two options, either give up driving or retain his access to medical marijuana for two years. He gave up access to medical marijuana, went on anxiety medication and completed his probation and later went back to using medical marijuana.

One of the public defenders working on Walton’s case, Cayne Duncan, in his brief, wrote that the judge is supposed to look at the facts of medical marijuana enrollment. He further wrote that the judge would be abusing the court’s powers by issuing a requirement for a doctor to present the facts written in the letter.

The district attorney defended the ruling saying that the judge acted within the authority, which stipulates that a doctor should appear and testify on the need for medical marijuana by the patient.

A case challenging the requirement for a doctor to testify in support of a convict’s need to continue using medical marijuana as they serve their probationary period is now before the State Supreme Court. Marijuana industry experts believe that companies like ChineseInvestors.com Inc. (OTCQB: CIIX) and MustGrow Biologics Corp. (CSE: MGRO) will be hoping that the highest court in the state removes the added requirements for people on parole who want to use medical marijuana to manage their health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) Finalizes Liquid Formulation of Mustard-Derived Bio-Pesticide

MustGrow Biologics (CSE: MGRO) (OTC: MGROF), an agricultural biotech company developing and commercializing a portfolio of natural, science-based bio-pesticides and bio-fertility products, this morning announced the finalization of its advanced liquid formulation. The new liquid formulation is an advancement of the company’s signature mustard-derived ‘granule format’ bio-pesticide product. In contrast to the granule format, the liquid formulation can be applied through standard drip or spray equipment and improves functionality and performance. Among other highlights, it has greater efficacy results per volume, a higher concentration of the active ingredient, and lower transportation costs. MustGrow’s liquid formulation work program was completed by National Research Council Canada (“NRC”). The NRC assessed control of hard-to-kill soil-borne diseases and application use-rates, especially diseases that have been challenging for many of Canada’s licensed cannabis producers. The NRC achieved 100% control of hard-to-kill soil borne diseases such as Botrytis and Fusarium using the company’s liquid formulation. Presently, MustGrow is undertaking additional testing to assess efficacy on other pests and further market applications in the food value chain, including storage container fumigation.

To view the full press release, visit http://cnw.fm/6vOeR

About MustGrow Biologics Corp.

MustGrow is a publicly traded (CSE: MGRO) (OTC: MGROF) agricultural biotech company focused on providing natural science-based biological solutions for cannabis and fruit & vegetable cultivation. In cannabis, the company is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. The company currently has three products suited for the cannabis market: a mustard-derived bio-pesticide, CannaProtector(R), to treat soil borne pests and diseases; a bio-fungicide, CannaVate(R), that can be used a foliar application for powdery mildew; and a bio-fertility product, TP-1000, to increase yield, THC and terpene levels. CannaVate(R) and TP-1000 are in-licenced products for which MustGrow has exclusive rights in Canada. CannaProtector(R) is based on MustGrow’s patented natural biologic technology made from mustard seed that acts as a bio-pesticide. MustGrow’s granular product is a United States EPA-approved organic solution that uses the mustard seed’s natural defence mechanism to protect plants from pests and diseases. Approximately CDN $10 million has been spent and over 110 independent tests completed, validating MustGrow’s safe and effective granular product. This product, which contains the same active ingredients as CannaProtector(R), is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s PMRA (Pest Management Regulatory Agency) as a fruit & vegetable bio-pesticide and fertilizer. MustGrow is positioning CannaProtector(R) as an effective pre-plant soil treatment, reducing the chance for any soil introduced to a greenhouse to bring in pests and diseases. The company expects its bio-pesticide will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops. The company has approximately 25.0 million basic common shares issued and outstanding and approximately 36.9 million on a fully diluted basis. For more information, visit the company’s website at www.Mustgrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://cnw.fm/MGRO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Texas Inexplicably Halts Medical Cannabis Dispensary Licensing Process

The Texas Department of Public Safety suspended the permit application process for medical marijuana dispensaries without warning.

According to the Department of Compassionate Use Program website, the department is currently not accepting any applications. Initially, the state had said that the application process would remain open from October 1 to November 1.

This announcement was quite a shock to advocacy groups that were looking to see the implementation of the expanded medical cannabis program since the list of qualifying conditions was expanded by the legislature to include ALS (amyotrophic lateral sclerosis), terminal cancer, autism, and seizures disorders. Initially, medical marijuana was used to treat only people with intractable epilepsy who fulfilled certain requirements.

The Department of Public Safety in Texas did not explain as to why the permit application process was halted.

The agency spokesperson wrote in an email saying that as the department works through the recent changes in the legislature regarding the program, it is assessing the dispensing capacity of the current license holders while checking if there is a need for additional medical marijuana dispensary licenses.

During the period which the application was to be open (October-November), the number of companies applying for the license was expected to be high. In 2017, among the 43 applicants who applied for the preliminary permits, only three were accepted. This included Surterra Texas, Cansortium, Texas, and Compassionate Cultivation.

According to the executive director of Texas NORML, Jax Finkel, the termination of the application process was a letdown as many patients were looking forward to comparing prices for a better deal on the CBD products once the licenses were approved. More permits meant the patients would access medical marijuana affordably.

Finkel further said that medical marijuana is expensive, and many patients pay thousands of dollars out of their pocket for the drug since insurance and Medicare do not provide cover for marijuana products. Competition would be stiff after issuing additional licenses which would promote a drop in the price of CBD products.

Finkel added that it is alarming for the state to suspend the application process a week into the process without warning or communication to the doctors, patients and the general public.

On Wednesday, the state Assembly representative Stephanie Klick who led the last legislative session to expand the Compassionate Use Act, said that the suspension of the application process is probably a temporary delay.

Experts believe the cannabis industry, including actors like MustGrow Biologics Corp. (CSE: MGRO) and ChineseInvestors.com Inc. (OTCQB: CIIX), could be disturbed that a process to give patients more options has been derailed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Key Details of the Massachusetts Marijuana Home Delivery System

Very soon, residents of Massachusetts may begin enjoying marijuana home delivery. New rules allowing marijuana companies to delivery cannabis direct to their customers were approved last week by the Massachusetts Cannabis Control Commission. After they were adopted, the commission created new licenses for companies specializing in marijuana delivery.

According to the Cannabis Control Commission (CCC), home delivery for medical marijuana patients had already been approved. However, the 2016 ballot measures do provide for legalization of recreational marijuana home delivery; allowing it would give marijuana companies a chance to enter a market that is controlled by black market operators.

Britte McBride, CCC Commissioner, wrote an opinion piece for CommonWealth Magazine that marijuana is here to stay. He added that licensed companies, which are regulated and tax-paying businesses, are in open competition with illegal home delivery. To curb the operation of illicitly delivered marijuana, the commission has come up with legislation (pending) to authorize monetary sanctions against unlicensed and unregulated businesses.

During the first two years, only those in the social equity program and locally owned businesses approved for home delivery will be given licenses.

To promote small and minority businesses, the commission issued two-year exclusive licenses, which will be effective immediately after the permit is issued, especially after seeing how black and Latino communities were affected by the war on drugs. After noting that to start a delivery company required little startup capital, the officials encouraged small entrepreneurs to participate.

Social equity program applicants must be residents of a community that qualifies for economic empowerment. Their income should also be below 40% of the federal poverty levels.

The new rules require marijuana delivery companies to enter into a contract with a licensed retailer if they are transporting other people’s products.

For home delivery, the customer has to confirm that they are 21 years or older at the dispensary and again when cannabis is delivered. Deliveries should only be done between 8 a.m. and 9 p.m., and the delivery people will be monitored by GPS and body cameras to make sure orders are delivered to the right place, and for the security of the employee.

Although cash payments are permitted, businesses are urged to implement an electronic or online payment system. The new rules prohibit carrying marijuana worth more than $10,000 at a time, to help minimize theft.

Deliveries will not be permitted in colleges or any university housing, shelters, hotels, or government-subsidized housing. Customers should order only from their place of residence. Also, deliveries will not be made in those parts of Massachusetts that do not permit the sale of marijuana.

To start companies to offer delivery services, the state and local officials have to approve delivery licenses, said Steve Hoffman, CCC chairman. However, first, they need to put the application form on their site, which will take several months since the commission isn’t accepting applications as yet.

Experts believe that the entire cannabis industry, including companies like MustGrow Biologics Corp. (CSE: MGRO) and ChineseInvestors.com Inc. (OTCQB: CIIX) is glad that people in Massachusetts will soon enjoy marijuana home delivery.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Benefits of Marijuana to People with Traumatic Brain Injury

Traumatic brain injury is a condition that is more common than most people care to admit. Research estimates that two million-plus people visit the ER each year with cases related to TBI. These cases occur from events such as car accidents, falls and physical attacks, and they result in minor concussion or severe traumatic brain injury. Fifty percent of the TBI injuries are connected to falls by children between the ages of 1-14 years and old folks over the age of 60. The World Health Organization lists TBI among the leading causes of death in young children.

To understand how people with TBI can benefit from using marijuana, we must first understand what traumatic brain injury means. Traumatic Brain Injury is the damage to the brain which is attributed to an external force. TBI can lead to premature death or permanent disability. TBI, like concussion, is most evident among football players and war veterans. Individuals suffering from TBI display symptoms such as dizziness, headaches, nausea, speech difficulties, difficulties controlling their motor function, sensitivity to light, seizures and amnesia.

Research shows that 30 clinical trials have failed to provide much-needed treatment for TBI. However, none of these trials included the use of cannabis which when used, activates the innate cannabinoid receptors, which help in reducing swelling in the brain and improve neurological impairment. When cannabinoid 2-AG is administered into a damaged mice’s brain, its cognitive and motor function are seen to improve significantly. Marijuana can also be used to treat other physiological conditions such as insomnia.

Studies show that Traumatic Brain Injury can result in brain edema, neural impairment, increase in microglial cell number, activation and DAI (diffuse axonal injury). The damage to the brain escalates cellular permeability thus allowing water to enter the brain which causes edema. Edema formation in humans can cause one to forget minor things such as their shopping list while impulsive behaviour and spatial learning and memory issues are observed in animals. Edema formation accounts for about fifty percent mortality rate of TBI patients. To treat edema, scientists applied the use of cannabinoid receptors (CB1 and CB2) as they help in decreasing brain edema.

However, through research CB1 receptors are less involved in the treatment effect of this drug. Thus to ensure effectiveness, scientists indicate that both receptors should be used together to increase the chances of neuroprotective actions. The study was successful because the scientists were in a lab setting, and they had the advantage of administering the dosage immediately after the accident. The research on the use of CB receptors on mice was led by Raphael Mechoulam and a top team from Hebrew University.

In the world of athletics, where the use of drugs is prohibited, it would be criminal to deny the administration of medical marijuana if a doctor determines that a single dose be administered immediately after concussion.

Experts are convinced that it is these types of findings that encourage cannabis companies like Marijuana Company of America Inc. (OTCQB: MCOAD) and MustGrow Biologics Corp. (CSE: MGRO) to keep working and making better products so that more people can benefit from what marijuana has to offer.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – DEA Wants 3,200 Kilos of Marijuana Grown Legally in 2020

Next year, the Drug Enforcement Administration (DEA) plans to authorize the cultivation of 3,200 kilos of marijuana that will be used for research and other federally-approved purposes.

This plan is part of the anti-narcotics agency’s annual quota for the production of controlled substances that will be used for the scientific, medical, research and industrial needs of the U.S. The quota also includes the amounts of controlled substances that are needed to address the lawful export needs of the country as well as maintaining reserve stocks of those controlled substances.

The planned volume of marijuana for 2020 indicates a 30 percent increase from the quota for 2019 which stood at 2.45 million kilos.

The planned amount is intended to meet the increased number of entities that have been approved to conduct marijuana research.

In a press released, the DEA indicated that during the past two years, there has been a steady increase in the number of marijuana research applicants from 384 in 2017 to 542 in 2019. This marks a 40 percent increase, the DEA added.

This increase in the amount of marijuana required by the DEA comes as the agency is set to approve more growers and manufacturers of the drug.

Last month, the federal agency revealed that it was now ready to act on the grower applications that it requested for three years ago.

If this promise is acted upon, the more than 50-year old monopoly by the University of Mississippi will come to an end and the research community, which has for long complained about the availability and quality of marijuana from that Mississippi farm, will heave a sigh of relief once alternative sources are available.

Recently, the director of this sole federally-licensed producer of research-grade cannabis made news by wondering why someone would want to consume marijuana with a THC concentration that exceeds 8 percent.

Those comments hammered home the research findings that indicated that the marijuana from the Mississippi farm is closer to hemp than the commercially available cannabis in states where marijuana has been legalized.

The notice in which the marijuana quota was announced indicates that the DEA plans to reduce the amount of other controlled substances manufactured. For example, fentanyl will be reduced by 31 percent, hydromorphone by 25 percent, and oxymorphone by 55 percent.

The agency will accept public comments about this quota until October 10 when the comments period will close.

Analysts think industry players like MustGrow Biologics Corp. (CSE: MGRO) and Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) will only be happy once the DEA actually licenses more research-grade marijuana manufacturers or growers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – FDA Seeks More Public Input on International Cannabis Rescheduling

The U.S. Food and Drug Administration (FDA) has again announced that it is receiving public comments about the possible reclassification of cannabis in international treaties.

The agency revealed in a federal register notice that it was opening a 30-day comments period on a matter about which it had received comments back in March but the comments period was shorter since the UN was due to meet shortly after to discuss the World Health Organization’s recommendation that marijuana and THC should be reclassified and that CBD shouldn’t be subjected to any international restrictions since it wasn’t addictive and didn’t carry any potential for abuse.

The expected discussion of the WHO’s recommendations didn’t take place in March as had been expected and the UN Commission on Narcotic Drugs agreed to postpone the inclusion of this matter on its agenda.

The FDA had earlier indicated that if the UN Narcotics Commission postponed consideration of the matter, then the federal agency would reopen the comments window. The notice published this week is a result of that promise and it allows the members of the public to share their views using electronic means or through mail.

Technically speaking, the reclassification of marijuana under the existing international treaties may not necessarily give UN member countries the liberty to legalize the drug since the rescheduling proposed by the World Health Organization (WHO) would still retain some degree of control on the drug.

However, any rescheduling would indicate that the UN, one of the most influential intergovernmental entities in the world, was recognizing that a lot more is now known about marijuana to warrant the organization to revisit its classification of this often controversial plant and its compounds.

The existing restrictions notwithstanding, countries are beginning to make their own decision to legalize recreational marijuana. Uruguay set the pace and Canada followed suit in 2018. By the end of this year, Mexico will have also legalized recreational marijuana in compliance with a Supreme Court ruling which declared that it was unconstitutional to bar adults from consuming recreational marijuana.

As for medical marijuana, one can almost fail to count all the countries that have either legalized it or are in the process of doing so. Medical marijuana has even gained acceptance in Asia (Thailand, for example) and yet this part of the world was notorious for its zero-tolerance for the drug.

Back home, the federal government through its different entities like the DEA, Congress and the National Institutes for Health (NIH) seems to be realizing that the marijuana tide cannot be stemmed for much longer and they are taking steps to ease cannabis research or even explore the best ways through which to reform the prohibitionist laws currently in force.

For now, industry watchers believe entities like Marijuana Company of America Inc. (OTCQB: MCOA) and MustGrow Biologics Corp. (CSE: MGRO) feel optimistic that the U.S. response to the proposed UN reclassification of marijuana will be favorable in light of all the positive public input that the FDA continues to receive each time it asks for such feedback.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com